
Monday, December 28, 2009 9:05:44 AM
All samples are currently being prepared to be sent out for assay, with results expected early in the New Year
TORONTO, ONTARIO -- (Marketwire) -- 12/17/09 --
Canadian Orebodies Inc. (TSX VENTURE: CO) ("Orebodies") is pleased to announce that it is has completed the purchase of 100% legal and beneficial interest (subject to a 2% NSR retained by the vendor, 50% of which can be purchased by Orebodies for $1,000,000) in 5 separate Lithium/Rare Metals properties (the "Properties") with an arm's length third-party vendor. The Properties in total consist of 111 claim units comprising 1,776 hectares, all which are located in Ontario
Project Update:
The previously announced work programs on the Properties which included detailed geological mapping and sampling across all 5 properties, mechanical stripping and systematic channel cuts across the Falcon West zone have now been successfully completed. All samples are currently being prepared to be sent out for assay, with results expected early in the New Year
Orebodies has cut small orientation grids over the showing areas on the Falcon property and have now commenced an orientation Gradiometeric Mag and VLF survey. It is further intended to conduct a resistivity survey over the orientation grids as conditions permit. The intention of the surveys is to determine the ability to trace and locate lithium bearing pegmatites by geophysical techniques for the purpose of distinguishing between pegmatite bearing veins and host rock
In addition, a small orientation down ice grid from the Falcon West was soil sampled to see if a Li bearing dispersal train could be detected from the showing area
More information regarding the Properties and locations is available on Orebodies website: www.canadianorebodies.com
Pursuant to the purchase, Orebodies has acquired 100% interest in the Properties by issuing an aggregate amount of 1,600,000 common shares of Orebodies and issuing 1,600,000 share purchase warrants, each warrant entitling the holder to acquire one common share of Orebodies at an exercise price of $0.15 per share for a period of two years from closing
The common shares of Orebodies issued are subject to a hold period until April 17, 2010
This press release has been prepared under the supervision of Mr. Don Hains (P.Geo.), who is an independent consultant to the Company and a "qualified person" (as such term is defined in National Instrument 43-101). Mr. Hains has verified the technical data disclosed in this press release
Forward Looking Information:
Some of the statements and information contained herein may be forward-looking information which involve known and unknown risks and uncertainties. Without limitation, statements regarding the, potential mineralization and resources, proposed exploration activities and future plans and objectives of Orebodies are forward looking statements that involve various degrees of risk. The following are important factors that could cause Orebodies actual results to differ materially from those expressed or implied by such forward looking statements: changes in the world wide price of mineral commodities, general market conditions, and the uncertainty of access to capital. In particular, there can be no assurance that the TSX Venture Exchange approval of the purchase will be obtained, or that Orebodies will undertake any or all of the payments or issuances necessary to complete the purchase
Contacts: Canadian Orebodies Inc
Gordon McKinnon President & CEO (705) 268-9000 www.canadianorebodies.com

Liked By
Spread the love. Be the first to like this post!
Recent CO News
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 03/03/2023 09:20:52 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/03/2023 07:39:34 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/03/2023 01:01:32 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/02/2022 09:07:25 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 10/31/2022 08:03:30 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 10/21/2022 09:15:41 PM
- Global Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman Islands • Business Wire • 09/26/2022 08:07:00 PM
- Global Cord Blood trading halted by NYSE for ‘regulatory concern’ • TipRanks • 09/23/2022 06:07:52 PM
- The Grand Court of the Cayman Islands Granted Blue Ocean’s Application to Appoint Joint Provisional Liquidators for Global Cord Blood Corporation • Business Wire • 09/23/2022 05:52:00 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 08/24/2022 01:02:32 PM
- Annual and Transition Report (foreign Private Issuer) (20-f) • Edgar (US Regulatory) • 08/16/2022 08:26:00 PM
- Global Cord Blood Corporation Files Annual Report on Form 20-F • PR Newswire (US) • 08/16/2022 08:16:00 PM
- Notification That Form 20-f Will Be Submitted Late (nt 20-f) • Edgar (US Regulatory) • 08/02/2022 12:01:19 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 07/06/2022 08:22:26 PM
- Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM • PR Newswire (US) • 07/06/2022 08:16:00 PM
- Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 • PR Newswire (US) • 07/05/2022 08:16:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 06/27/2022 12:02:30 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 06/22/2022 08:01:30 PM
- Global Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for IND • Dow Jones News • 06/17/2022 04:49:00 PM
- Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis • PR Newswire (US) • 06/16/2022 08:20:00 PM
- Shareholders Led by Blue Ocean Announce Successful Results of Extraordinary General Meeting of Global Cord Blood Corporation • Business Wire • 06/16/2022 08:05:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 06/16/2022 12:38:47 PM
- Global Cord Blood Corporation Announces Purported EGM Is Not Validly Convened • PR Newswire (US) • 06/16/2022 12:30:00 PM
- Shareholders of Global Cord Blood Corporation Are Reminded to Comply with the Rules of Conduct When Attending the Extraordinary General Meeting and Exercising Their Voting Rights • Business Wire • 06/15/2022 11:38:00 AM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 06/15/2022 10:41:02 AM
Hollywall Entertainment Inc., (OTC:HWAL) Announces the completion of its 2021 and 2020 Audit (s) • HWAL • Mar 24, 2023 12:48 PM
Glucose Health, Inc. Fiscal 2022 Annual Report • GLUC • Mar 23, 2023 3:23 PM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • TMC • Mar 22, 2023 1:44 PM
Fineqia Announces Partnership with Paris Blockchain Week to Accelerate Digital Asset Innovation • FNQQF • Mar 22, 2023 10:03 AM
E-Cite and ClearMarket Launch Nationwide EV Distribution Network Becoming the First All EV Dealership Opening in the Cerritos Auto Square, the World's Largest Automall • VAPR • Mar 22, 2023 9:41 AM